Repayment of Lind Facility with Successful Capital Raise
Filed with ASX · · 3 pages · English
Earlier from Invion
- Response to ASX Aware Letter
- Appendix 4E and Annual Report
- Response to ASX Price Query
- Orphan Drug Designation Granted by U.S. FDA For Anal Cancer
- Appendix 4C and Quarterly Activities Report - June 2025
Later from Invion
- Funded Collaboration Agreement with Protect Animal Health
- Appendix 4C and Quarterly Activities Report - September 2025
- Invion Secures Expanded Photosoft Global Exclusive License
- Hanlim & Korean Government Fund Pathway to Clinical Trial
- Pause in Trading
Follow Invion into a list and get an email when it puts out news.
Follow Invion